NL-OMON35800已完成2 期
Evaluation of the PneumRx, Inc. Lung Volume Reduction Device for the Treatment of Subjects with Homogeneous Emphysema - LVR-coil study CLN0012
PneumRx0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Homogeneous emphysema on CT-thorax
- •Post-bronchodilator FEV1 < 35% predicted
- •Total Lung Capacity > 120% predicted
- •Residual Volume > 225% predicted
- •mMRC dyspnea score >2
- •Stopped smoking > 6 months
排除标准
- •History of recurrent respiratory infections
- •Cardiovasculair pathology
- •Inability to walk > 140 meters in 6 minutes
- •Giant bullae (> 1/3 lung volume)
- •Patient is taking > 20 mg prednisone (or similar steroid) daily
- •Patient has evidence of other disease that may compromise survival (such as lung cancer, renal failure etc)
研究者
相似试验
已完成
不适用
Evaluation of the PneumRx, Inc. Lung Volume Reduction Device for the Treatment of Emphysema.COPD10038716EmphysemaNL-OMON35583PneumRx, Inc20
撤回
不适用
Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin DeficiencyAlpha-1-Antitrypsin DeficiencyChronic Obstructive Lung DiseaseEmphysemaNCT02273349University Hospital, Saarland
已完成
不适用
Evaluation of the PneumRx Lung Volume Reduction Coil to Treat EmphysemaEmphysemaNCT01220908Boston Scientific Corporation36
已完成
2 期
Feasibility Study of the PneumRx, Inc. Lung Volume Reduction Coil for the Treatment of EmphysemaEmphysemaCOPD10038716NL-OMON36664PneumRx, Inc20
已完成
不适用
ung Volume Recruitment in Neuromuscular Disease: Can ‘breath-stacking’ improve lung function, respiratory symptoms and quality of life for people with neuromuscular disease?Spinal cord injuryACTRN12615000565549Institute for Breathing and Sleep80